Two-Year Recurrence After First-Ever Stroke in a General Population of 1.4 Million Japanese Patients - The Shiga Stroke and Heart Attack Registry Study.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 05 2020
Historique:
pubmed: 1 5 2020
medline: 15 12 2020
entrez: 1 5 2020
Statut: ppublish

Résumé

Despite many effective strategies for the prevention of recurrent stroke, individuals who survive an initial stroke have been shown to be at high risk of recurrent stroke. The aim of this study was to investigate the current status of stroke recurrence after first-ever stroke using a population-based stroke registry in Japan.Methods and Results:As part of the Shiga Stroke and Heart Attack Registry, the Shiga Stroke Registry is an ongoing population-based stroke registry study that covers approximately 1.4 million residents of Shiga Prefecture, Japan. A total of 1,883 first-ever stroke survivors at 28 days was registered in 2011 and followed-up until the end of 2013. Recurrence was defined as any type of stroke after 28 days from the onset of an index event. Two-year cumulative recurrence rates were estimated using cumulative incidence function methods. Over a mean 2.1-year follow-up period, 120 patients experienced recurrent stroke and 389 patients died without recurrence. The 2-year cumulative recurrence rate was higher in patients with index ischemic stroke (6.8%) than in those with index hemorrhagic stroke (3.8%). Two-year cumulative recurrence rate after first-ever stroke remained high, particularly among patients with ischemic stroke, in the present population-based registry study in a real-world setting in Japan. Further intensive secondary prevention strategies are required for these high-risk individuals.

Sections du résumé

BACKGROUND
Despite many effective strategies for the prevention of recurrent stroke, individuals who survive an initial stroke have been shown to be at high risk of recurrent stroke. The aim of this study was to investigate the current status of stroke recurrence after first-ever stroke using a population-based stroke registry in Japan.Methods and Results:As part of the Shiga Stroke and Heart Attack Registry, the Shiga Stroke Registry is an ongoing population-based stroke registry study that covers approximately 1.4 million residents of Shiga Prefecture, Japan. A total of 1,883 first-ever stroke survivors at 28 days was registered in 2011 and followed-up until the end of 2013. Recurrence was defined as any type of stroke after 28 days from the onset of an index event. Two-year cumulative recurrence rates were estimated using cumulative incidence function methods. Over a mean 2.1-year follow-up period, 120 patients experienced recurrent stroke and 389 patients died without recurrence. The 2-year cumulative recurrence rate was higher in patients with index ischemic stroke (6.8%) than in those with index hemorrhagic stroke (3.8%).
CONCLUSIONS
Two-year cumulative recurrence rate after first-ever stroke remained high, particularly among patients with ischemic stroke, in the present population-based registry study in a real-world setting in Japan. Further intensive secondary prevention strategies are required for these high-risk individuals.

Identifiants

pubmed: 32350232
doi: 10.1253/circj.CJ-20-0024
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

943-948

Auteurs

Naoyuki Takashima (N)

Department of Public Health, Shiga University of Medical Science.
Department of Public Health, Kindai University Faculty of Medicine.

Hisatomi Arima (H)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University.

Yoshikuni Kita (Y)

Department of Public Health, Shiga University of Medical Science.
Tsuruga Nursing University.

Takako Fujii (T)

Department of Neurosurgery, Shiga University of Medical Science.
Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University.

Sachiko Tanaka-Mizuno (S)

Department of Medical Statistics, Shiga University of Medical Science.

Satoshi Shitara (S)

Department of Neurosurgery, Shiga University of Medical Science.

Akihiro Kitamura (A)

Department of Neurology, Shiga University of Medical Science.

Katsuyuki Miura (K)

Department of Public Health, Shiga University of Medical Science.
Center for Epidemiologic Research in Asia, Shiga University of Medical Science.

Kazuhiko Nozaki (K)

Department of Neurosurgery, Shiga University of Medical Science.
Center for Epidemiologic Research in Asia, Shiga University of Medical Science.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH